Pharmaceutical drug pricing and reimbursement remains a bipartisan focus as we draw closer to the November presidential elections, with politicians remaining steadfast in their efforts to turn up the heat on pharmaceutical...more
EU – REGULATORY -
Brexit, Notified Bodies, and Medical Devices -
The House of Commons Library published a briefing paper on June 12 on the UK’s product standards and safety marking compliance in light of Brexit. In the...more
8/20/2019
/ Anti-Kickback Statute ,
Asia ,
China ,
Competition ,
Data Privacy ,
Drug Pricing ,
EU ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
Life Sciences ,
Medical Devices ,
Patents ,
Pharmaceutical Industry ,
UK Brexit
Pharmaceutical and agricultural companies in particular should consider the effect of Brexit on their European patent portfolios.
Supplementary Protection Certificates (SPCs) are governed by EU regulations and are thus...more
7/7/2016
/ Agricultural Sector ,
EU ,
Intellectual Property Protection ,
Member State ,
Patent Portfolios ,
Patents ,
Pharmaceutical Industry ,
Popular ,
Referendums ,
Supplementary Protection Certificate ,
UK ,
UK Brexit ,
UK Patent Act